Overview

Pharmacokinetics of GATE-251 in Fasted or Fed State

Status:
RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the effect of food on the rate and extent of absorption of a single dose of GATE-251 3 mg or 10 mg oral tablets tablets in healthy adult volunteers.
Phase:
PHASE1
Details
Lead Sponsor:
Syndeio Biosciences, Inc
Collaborator:
Dr. Vince Clinical Research